Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Thomas E. Lew being referenced
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax
2020
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas E. Lew | 554 | 414 | 123 | 211 | 32 | 846 | |
| E. Januszewicz | 456 | 398 | 64 | 127 | 41 | 940 | |
| G. Laurent | 218 | 216 | 72 | 206 | 30 | 743 | |
| W.Y. Au | 158 | 152 | 51 | 174 | 37 | 694 | |
| Gaetano Vitelli | 287 | 156 | 39 | 298 | 28 | 654 | |
| Sharon Jackson | 191 | 351 | 53 | 136 | 29 | 794 | |
| Deborah Yallop | 417 | 198 | 22 | 217 | 35 | 757 | |
| Jennifer Dunlap | 223 | 167 | 117 | 356 | 36 | 934 | |
| Ozren Jakšić | 395 | 226 | 33 | 180 | 47 | 831 | |
| Elizabeth Bilotti | 573 | 451 | 57 | 231 | 29 | 814 | |
| L. Austin Doyle | 145 | 242 | 197 | 329 | 33 | 905 |
All Works
Login with ORCID to disown or claim papers
Loading papers...